UK Approves New Valneva COVID 19 Vaccine

• The United Kingdom government has approved a new coronavirus vaccine by the Austrian-French drugmaker, Valneva

• The approval was granted after the Valneva COVID 19 vaccine was adjudged to have met the required safety, quality, and effectiveness standards

• The Austrian-French firm has signed an agreement with the European Commission to deliver up to 60 million doses of the vaccine in 2022

Britain has approved a new COVID 19 vaccine from Austrian-French drugmaker Valneva, the country’s health regulator announced on Thursday.

A statement which was released by the Medicines and Healthcare products Regulatory Agency disclosed that the vaccine had passed all required safety, quality, and effectiveness standards.

This comes after the Valneva COVID 19 vaccine received its first approval for an emergency authorization for use in Bahrain last month.

Meanwhile, the drug company had committed to supplying the Middle-eastern kingdom with one million doses after an advanced purchase agreement was struck last year.

Valneva also signed another agreement with the European Commission for the supply of up to 60 million doses in 2022 and 2023.

Valneva’s COVID 19 vaccine uses the traditional technology of inactivated virus and CEO Thomas Lingelbach has suggested that this authorization could pave the way for the availability of an alternative vaccine for Britain.

Read also: England Rolls Out 4th Jab of COVID Vaccine For Virus Protection

Valneva is the sixth coronavirus vaccine to be approved in the United Kingdom, following approvals for AstraZeneca, Pfizer, Moderna, Johnson & Johnson, and Novavax.

The vaccine is approved for use in people between the ages of 18 and 50, with the second dose to be taken at least 28 days after the first.

Follow Naija.fm on social media handles: Facebook, Instagram, and Twitter for trending news, entertainment news, and hot gist.